To the best of our knowledge, treatment with antibodies directed against other cell antigens (e.g., anti-CD3, -CD28, -CD127, or -CD137) that promote immune tolerance in transplantation, GVHD, or autoimmune diseases has not been reported in other animal models of DMD. This evidence concerns the gene IL7R and graft versus host disease.